Kathleen Richton
Förmögenhet: 12 696 $ per 2026-08-31
Förmögenhet: 12 696 $ per 2026-08-31
Ms. Kathleen Richton is a Senior VP, Chief Financial & Accounting Officer at enGene Therapeutics, Inc. Ms. Richton was previously employed as a Vice President & Controller by Sunovion Pharmaceuticals, Inc. She received her undergraduate degree from Bentley University and a graduate degree from Bentley University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ENGENE THERAPEUTICS INC. 0,01 % | 2026-07-16 | 6 900 ( 0,01 % ) | 12 696 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Finansdirektör/CFO | 2026-07-16 |
| Företag | Position | Slut |
|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Comptroller/Controller/Revisor | 2023-07-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
enGene Holdings, Inc.
enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån